Search research articles
Contact Us
Filters
Showing results (611-620 of 1,066) with videos related to
Page
of 107
Sort By:
Gastroenterology
|
August 10, 2000
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells
P Failli, R M DeFRANCO, A Caligiuri, et al.
Blood
|
July 23, 2005
Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies
Kenneth D Lute, Kenneth F May, Ping Lu, et al.
Plos One
|
January 30, 2010
Macrophage plasticity in experimental atherosclerosis
Jamila Khallou-Laschet, Aditi Varthaman, Giulia Fornasa, et al.
The Journal of Clinical Investigation
|
April 15, 2025
Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice
Zhenyu Dai, Zheng Zhu, Zhiyao Li, et al.
Nature Immunology
|
April 29, 2022
ILC1s control leukemia stem cell fate and limit development of AML
Zhenlong Li, Rui Ma, Shoubao Ma, et al.
Journal of Neurology
|
July 22, 2017
Structural connectivity differences in essential tremor with and without resting tremor
Maria Eugenia Caligiuri, Gennarina Arabia, Gaetano Barbagallo, et al.
Circulation
|
November 15, 1996
Plasma protein acute-phase response in unstable angina is not induced by ischemic injury
G Liuzzo, L M Biasucci, A G Rebuzzi, et al.
The Journal of Clinical Investigation
|
January 1, 1993
Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2
M A Caligiuri, C Murray, M J Robertson, et al.
Blood
|
July 12, 2008
The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele
Adrienne M Dorrance, Shujun Liu, Anita Chong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity
Syed-Rehan A Hussain, Carolyn M Cheney, Amy J Johnson, et al.
Page
of 107
Search research articles
Search
Showing results (611-620 of 1,066) with videos related to
Sort By:
Page
of 107
Gastroenterology
|
August 10, 2000
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells
P Failli, R M DeFRANCO, A Caligiuri, et al.
Blood
|
July 23, 2005
Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies
Kenneth D Lute, Kenneth F May, Ping Lu, et al.
Plos One
|
January 30, 2010
Macrophage plasticity in experimental atherosclerosis
Jamila Khallou-Laschet, Aditi Varthaman, Giulia Fornasa, et al.
The Journal of Clinical Investigation
|
April 15, 2025
Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice
Zhenyu Dai, Zheng Zhu, Zhiyao Li, et al.
Nature Immunology
|
April 29, 2022
ILC1s control leukemia stem cell fate and limit development of AML
Zhenlong Li, Rui Ma, Shoubao Ma, et al.
Journal of Neurology
|
July 22, 2017
Structural connectivity differences in essential tremor with and without resting tremor
Maria Eugenia Caligiuri, Gennarina Arabia, Gaetano Barbagallo, et al.
Circulation
|
November 15, 1996
Plasma protein acute-phase response in unstable angina is not induced by ischemic injury
G Liuzzo, L M Biasucci, A G Rebuzzi, et al.
The Journal of Clinical Investigation
|
January 1, 1993
Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2
M A Caligiuri, C Murray, M J Robertson, et al.
Blood
|
July 12, 2008
The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele
Adrienne M Dorrance, Shujun Liu, Anita Chong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity
Syed-Rehan A Hussain, Carolyn M Cheney, Amy J Johnson, et al.
Page
of 107